PURPOSE. Approximately 8% of autosomal recessive retinitis pigmentosa (RP) cases worldwide are due to defects in rodspecific phosphodiesterase PDE6, a tetramer consisting of catalytic (PDE6␣ and PDE6␤) and two regulatory (PDE6␥) subunits. In mice homozygous for a nonsense Pde6b rd1 allele, absence of PDE6 activity is associated with retinal disease similar to humans. Although studied for 80 years, the rapid degeneration Pde6b rd1 phenotype has limited analyses and therapeutic modeling. Moreover, this model does not represent human RP involving PDE6B missense mutations. In the current study the mouse missense allele, Pde6b H620Q was characterized further.
PURPOSE. Approximately 8% of autosomal recessive retinitis pigmentosa (RP) cases worldwide are due to defects in rodspecific phosphodiesterase PDE6, a tetramer consisting of catalytic (PDE6␣ and PDE6␤) and two regulatory (PDE6␥) subunits. In mice homozygous for a nonsense Pde6b rd1 allele, absence of PDE6 activity is associated with retinal disease similar to humans. Although studied for 80 years, the rapid degeneration Pde6b rd1 phenotype has limited analyses and therapeutic modeling. Moreover, this model does not represent human RP involving PDE6B missense mutations. In the current study the mouse missense allele, Pde6b
H620Q was characterized further.
METHODS. Photoreceptor degeneration in Pde6b
H620Q homozygotes was documented by histochemistry, whereas PDE6␤ expression and activity were monitored by immunoblotting and cGMP assays. To measure changes in rod physiology, electroretinograms and intracellular Ca 2ϩ recording were performed. To test the effectiveness of gene therapy, Opsin::Pde6b lentivirus was subretinally injected into Pde6b H620Q homozygotes.
RESULTS. Within 3 weeks of birth, the Pde6b
H620Q homozygotes displayed relatively normal photoreceptors, but by 7 weeks degeneration was largely complete. Before degeneration, PDE6␤ expression and PDE6 activity were reduced. Although light-/dark-adapted total cGMP levels appeared normal, Pde6b H620Q P hotoreceptor degenerations are a significantly large group of neurodegenerative disorders. [1] [2] [3] In patients with retinitis pigmentosa (RP), early symptoms include night blindness and loss of peripheral vision due to rod photoreceptor degeneration. Cone death follows and results in loss of daytime central vision. Approximately 8% of cases of recessive RP worldwide are due to mutations in rod-specific PDE6 complex (Huang SH, et al. IOVS 1995; 36 :ARVO E-Abstract 3815), 4 -7 consisting of catalytic (PDE6␣ and PDE6␤) and regulatory (PDE6␥) subunits. 8 -26 Approximately 70% of rod-associated, PDE-based, RP cases are associated with missense mutations within the PDE6␤ catalytic domain, probably resulting in only partial loss of enzyme function. 27, 28 PDE6 is the effector enzyme of the G-protein-mediated visual transduction cascade. Light entering rod outer segments (OS) activates the photopigment that stimulates PDE6 enzyme activity via the photoreceptor-specific G-protein transducin. Activated PDE6 decreases the concentration of free cGMP approximately 10-fold on a millisecond time-scale. 29 Prolonged exposure to light and PDE6 activity results in a two-fold difference between dark-and light-adapted total cGMP levels. 9, 30, 31 Reductions in free cGMP concentration results in the closing of cGMP-gated cationic channels (CNG). A decrease in Na ϩ and Ca 2ϩ influx through the CNG generates a membrane current change that hyperpolarizes the photoreceptor and decreases the release of neural transmitter at the synapse. 14, 18, 32 The Pde6b rd1 mouse has been used to study photoreceptor degeneration and as a therapeutic model for human RP.
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Pde6b
rd1 is a null allele and is not detectably expressed presumably due to nonsense-mediated mRNA decay. 36, 37 Homozygous mutant mice exhibit rapid rod and subsequent cone degeneration. 35 As expected, PDE6 activity is absent, there is no difference in dark-and light-adapted total cGMP levels, which are dramatically increased over the control. It has been hypothesized that this high level of total cGMP promotes rod cell death.
Attempts to treat Pde6b rd1 mice with gene therapy have had limited success. 38 -41 In particular, long-term functional restoration of retinal signaling has not been achieved, perhaps because of the rapid nature of the degeneration in the Pde6b rd1 mouse, the therapeutic strategy, and/or the level of intervention in the neurodegeneration pathway.
A 
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Histochemical Analyses
Mice were euthanatized with an intraperitoneal injection of pentobarbital. Each eye was rapidly removed, punctured at the 12 o'clock position along the limbus, and placed in a separate solution of 3% glutaraldehyde in phosphate-buffered saline. After fixation for 1 to 2 days, the eyes were washed with saline, and the puncture was used to orient the eyes so that the posterior segment could be sectioned along the vertical meridian. Eyes were dehydrated and embedded in paraffin. Hematoxylin-eosin (H&E) staining of paraffin-embedded sections was conducted as described. 46 Quantification of photoreceptor nuclei was conducted on several sections containing the optic nerve as follows: the distance between the optic nerve and the ciliary body was divided into quadrants, and three rows of nuclei were counted within each quadrant. Averages and standard deviations were calculated from 3 to 15 animals for each time-point.
For electron microscopy (EM), a rectangular piece of the retina, containing the superior to inferior ora serrata and optic nerve, was prepared for postfixation in osmic acid, dehydrated, and Epon embedded. A corner was cut out at the superior ora to allow identification of the upper retinal half of the segment. Sectioning proceeded along the long axis of the segment so that each section contained upper and lower retina as well as posterior pole. Semiserial sections were stained with either H&E or toluidine blue, mounted, and examined by light microscopy. Selected areas were trimmed for ultrathin sectioning, stained with uranyl acetate, and examined by EM. 8, 9, 47, 48 
Total cGMP Assays
Direct retinal cGMP content and PDE assays were performed as described. 8, 9, 12, 46 For total cGMP, the retinas were isolated under infrared illumination or normal room light and homogenized in 0.1 N HCl. Measurement of cGMP was conducted in triplicate, and the results expressed in picomoles cGMP per nanogram total protein.
PDE6 Purification and cGMP Phosphodiesterase Assay
PDE6 was extracted from retinal membranes using a hypotonic buffer according to the method of Kühn. 49 In brief, light-adapted retinas were homogenized in 100 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 supplemented with protease inhibitors (Calbiochem, San Diego, CA). After centrifugation for 2 minutes, the supernatant was discarded, and the pellet was washed. PDE6 was extracted twice from the pellet with 5 mM Tris-HCl (pH 7.5) supplemented with 1 mM MgCl 2 . These supernatants were pooled and concentrated (Centricon-3; Amicon, Beverly, MA) and the protein concentration determined according to Lowry. Samples were adjusted to 70 ng total protein/sample for the PDE assay. Samples (5 L) were incubated with 20 L cGMP (0.5 mM stock solution), 10 L snake venom (3.7 mg/mL stock solution), and 15 L assay buffer for 30 minutes at 37°C with gentle rotating. 50 The reaction was stopped with 100 L green reagent, and the color was allowed to develop for 30 minutes at room temperature (BioMol, Plymouth Meeting, PA). The OD was measured at 620 nm. The cleavage of cGMP to 5Ј-GMP by PDE was determined as phosphate release from 5Ј-GMP with the linkage of 5Ј-nucleotidase reaction.
Western Blot Analysis
Retinas were homogenized in 10% sodium dodecyl sulfate (SDS) by brief sonication and denatured at 100°C for 5 minutes. After centrifugation, total protein content per sample was determined by a protein assay method (D C Protein Assay; Bio-Rad Laboratories, Hercules, CA). The proteins were separated by SDS-polyacrylamide gel electrophoresis. Samples were then transferred to nitrocellulose membranes, which were blocked in 3% BSA in 500 mM NaCl, 20 mM Tris (pH 7.6), and 0.1% Tween-20 (BSA-TTBS). Membranes were incubated with either rabbit anti-PDE6␤ (1 g/mL, PAI-722; Affinity Bioreagents, Golden, CO) or mouse anti-OPSIN (1:1000, ID4 51 ) antibodies in BSA-TTBS. After washing in TTBS, filters were incubated with either anti-rabbit-or anti-mouse-conjugated horse radish peroxidase secondary antibodies 
Measurement of Intracellular Calcium
Spot laser epifluorescence was used to determine the concentration of Ca 2ϩ in living rod OS from retinas loaded with fluo5F (InvitrogenMolecular Probes, Eugene OR). 52, 53 OS fluorescence was collected with 505-nm dichroic and 510-nm long-pass filters (Omega Optical, Brattleboro, VT).
Construction and Transduction of Lentiviral Vectors
The Opsin::Pde6b vector was constructed using 2 kb of the mouse Opsin promoter region and a full-length mouse Pde6b cDNA fragment. 54 Self-inactivating (SIN) vectors consist of a 5Ј-long terminal repeat (LTR), a packaging signal , a tRNA primer binding site, a lentiviral reverse response element, the mouse Opsin promoter linked to Pde6b, and 3ЈLTR. The vector also contains a central polypurine tract/DNA flap 55 and a Woodchuck hepatitis virus posttranscriptional regulatory element. The Opsin::Pde6b, EF::Green Fluorescent Protein (GFP) vector contains a 5ЈLTR, a retroviral export element, a lentiviral Rev-response element, the mouse Opsin promoter linked to Pde6b, EF1::GFP, and the U5 region of the 5ЈLTR, and the 3ЈLTR was also used. GFP expression is driven by the EF1 promoter. Virus was generated by cotransfection of human kidney-derived 293T cells with vectors and packaging constructs using the Ca 2ϩ phosphate method 56 -58 (Biogenova Corp., Ellicott City, MD and Lentigen Corp., Baltimore, MD). Anesthesia and surgery were preformed as described. 59 
Electroretinograms
ERGs were performed as described. 8, 9, 46, 49, 60 The mice were darkadapted overnight, manipulations were conducted under dim red light illumination, and recordings were made (Espion ERG Diagnosys equipment; Diagnosys LLL, Littleton, MA). Adult C57BL/6 mice were tested at the beginning of each session as controls. Mice were anesthetized by intraperitoneal injection of (per 10 g body weight) 0.1 mL mix (1 mL ketamine 100 mg/mL and 0.5 mL xylazine 20 mg/mL in 8.5 mL PBS). The corneas were anesthetized with a drop of 0.5% proparacaine hydrochloride (Alcon Laboratories, Inc., Fort Worth, TX) and pupils were dilated with topical 2.5% phenylephrine hydrochloride and 1% tropicamide. Body temperature was maintained at 37°C with a heating pad. Burian-Allen bipolar mouse contact lens electrodes (Hansen Laboratories, Coralville, IA) were placed on each cornea, after application of gonioscopic prism solution (Alcon Laboratories). The reference electrode was placed SC in the anterior scalp between the eyes, and the ground electrode was inserted into the tail. Electrode impedance was balanced for each eye pair measured. The head of the mouse was placed in a standardized position in a Ganzfeld bowl illuminator that assured equal illumination of the eyes. Both eyes were recorded simultaneously.
For rod and mixed rod-cone responses, ERGs for dark-adapted mice were recorded using pulses of 0.001 30 and 3 cd-s/m 2 (white 6500K), respectively. A total of 40 responses were averaged for each trial. For photopic responses, mice were light adapted in the Ganzfeld dome for at least 10 minutes. A rod-suppressing steady background of 30 cd/m 2 (white 6500K) was continuously present throughout the trials. ERGs were recorded using pulses of 30 cd-s/m 2 (xenon). A total of 40 responses (filtered from 0.03 to 300 Hz) were averaged for each trial.
RESULTS
Hart et al., 42 described a new mouse Pde6b mutant line (Pde6b H620Q ) that demonstrates delayed photoreceptor degeneration, compared to Pde6b rd1 mice. We extended their studies by performing histologic, biochemical, and physiological measurements and by testing the ability of gene therapy to ameliorate degeneration. For our studies, age-matched DBA/2J or C57BL6 were used as control subjects, [42] [43] [44] [45] which are not congenic with the C3H strain.
Delayed Photoreceptor Degeneration in
Pde6b H620Q Homozygous Mutants
Previously, Pde6b H620Q photoreceptor degeneration was documented at P21 and P42. 42 To further quantify the rate of degeneration, we performed a histologic analysis of Pde6b H620Q mutant photoreceptors between P9 and P64 (Fig.  1A, 1B) . Although the number of photoreceptors between Pde6b H620Q mutant and control mice was similar at P9 and P14, nuclei numbers progressively diminished from P19 through P49. Afterward, one to two rows of nuclei remained from P56 through P77. The remaining layer contained cones, as demonstrated by peanut agglutinin staining (see Fig. 5E , bottom left). Modest differences in the rate of degeneration were observed between the optic nerve and ciliary body; degeneration of peripheral photoreceptors was slower than that of the central photoreceptors (Fig. 1B) .
Our H&E analysis suggests, before extensive degeneration, mutant OS are present and intact. To confirm this finding, we examined mutant retinas by transmission EM (Fig. 1C) . We find at P21, the inner segments (IS) and OS of Pde6b H620Q photoreceptors segments are mildly disorganized but have normally spaced discs.
Progressive Retinal Dysfunction in Pde6b
H620Q
Homozygous Mutants
Our histologic analyses suggest the mutant retinas are functional before extensive degeneration. We therefore used ERG analyses to assess global retinal function in Pde6b H620Q mutant mice from P20 through P55 (Fig. 2) .
Rods. Compared with wild-type, P20 mutant maximum rod-specific b-wave peaks were depressed and delayed (e.g., 
IOVS,
148 V vs. 43 V; 70 ms vs. 119 ms; Fig. 2 ). In mutants older than P20, rod responses are weaker or extinguished. Mixed Rod-Cone. In P20 mutants, the maximum rod-cone responses, a-and b-wave peaks, are smaller in amplitude and delayed compared to WT mice, although the differences are not as striking as the isolated rod responses (Fig. 2) . Reductions in rod-cone responses and increased variation between animals were observed in older mutants.
Transient Photopic Cone. Cone responses in P20 mutant retinas also showed amplitude reductions and delays in implicit time, compared with WT controls (Fig. 2) . Changes in photopic cone responses over time and between animals were similar to the mixed rod-cone responses.
Photopic 30-Hz Flicker Responses. We observed no significant delay in the implicit time up to P55 (Fig. 2, right) .
These results indicate that the Pde6b H620Q mutant mice had detectable photoreceptor function that progressively decreased. Initially, both rod-and cone-specific ERGs were depressed and delayed, possibly due to low PDE6 activity, photoreceptor loss, and/or inner retinal changes. Rod and cone responses were reduced in progressively older mice, with losses in rod function preceding cone changes.
Loss of PDE6 Function in Pde6b
H620Q
Homozygous Mutant Mice
The Pde6b H620Q allele is defined as hypomorphic, as the phenotype of the Pde6b H620Q /Pde6b rd1 compound heterozygotes is intermediate between Pde6b
H620Q homozygotes and Pde6b rd1 homozygotes. 42 As the H620Q missense mutation is located within the H-loop of the PDE6␤ catalytic domain, loss of function may be due to a decrease in PDE6 activity. 61 Alternatively, loss of function may be attributable to the reduced level of the enzyme. To test these hypotheses, we analyzed PDE6␤ expression and PDE6 biochemical function in Pde6b H620Q mutant and control mice. We first measured PDE6␤ expression in Pde6b H620Q mutants. Western blot analysis of total retinal homogenates using anti-PDE6␤ antibodies demonstrated that PDE6␤ was expressed at lower levels in Pde6b H620Q mutant retinas than in wild-type retinas (Figs. 3A, 3B ). For these experiments, retinas from P16 or P18 were analyzed. Equivalent amounts of total protein were loaded for mutant and control mice, as confirmed by similar levels of OPSIN expression in the samples. Densitometric analysis of the Western signals indicated that PDE6␤ was expressed at ϳ22-fold lower levels in mutants than in controls (Figs. 3A, 3B) .
We then investigated whether Pde6b H620Q homozygous mutant retinas exhibit reduced PDE6 activity. PDE6 was extracted according to the method of Kühn. 49 After homogenization, PDE was isolated from washed membranes by extraction in hypotonic buffer and concentrated, and the total protein content was determined. PDE activity was then measured in P20 control and mutant extracts. In wild-type samples, average light-activated PDE was 0.392 picomoles cGMP hydrolyzed/ng protein/min, whereas Pde6b H620Q homozygote extracts were 0.006 pmol cGMP hydrolyzed/ng protein/min (ϳ65 times more wild-type activity per nanogram extract protein than mutant activity). Since PDE6␤ was expressed at lower levels in retinal homogenates, we measured the amount of PDE6␤ present in these crude hypotonic extracts by densitometric analysis of immunoblots. We loaded amounts of wildtype (0.3 g) and mutant (20 g) extracts estimated to induce nearly identical activity (ϳ3.6 nanomoles cGMP hydrolysis in 30 minutes) and detected ϳ7.7 times more PDE6␤ in the mutant samples than in the wild-type. Normalizing wild-type and mutant PDE activity to PDE6␤ content gave 0.347 picomoles cGMP hydrolyzed/PDE6␤ IDV/minute and 0.046 picomoles cGMP hydrolyzed/PDE6␤ IDV/minute, respectively (ϳ7.5 times more wild-type than mutant; Fig. 3C ). Thus, in these experiments, we can estimate the specific activity of mutant PDE6 at ϳ13% of wild-type PDE. Together, these biochemical and expression results are consistent with Pde6b H620Q 's being a hypomorphic allele. 
Measurement of Total cGMP Levels in Pde6b
H620Q
Homozygous Mutant Mice
Reduced PDE6 activity may result in the abnormal accumulation of total cGMP levels in Pde6b H620Q mutant retinas. Indeed, Pde6b rd1 null mice, which contain no detectable PDE6␤ expression or PDE6 activity, exhibit an abnormal increase in light-adapted total cGMP levels before onset of degeneration. [43] [44] [45] To explore this possibility, we measured and compared total cGMP levels between Pde6b rd1 mutant, Pde6b H620Q mutant, and control retinas (Fig. 4) . In Pde6b rd1 mutants (C3H strain), we found changes in total cGMP (rise-and-fall profile and light-adapted cGMP levels) that were consistent with those in previous reports, supporting the validity of our methodology (Fig. 4A) . [43] [44] [45] In Pde6b H620Q mutants, we observed differences in cGMP levels between light-and dark-adapted retinas (compare gray and black lines) and total cGMP levels that decreased in parallel with photoreceptor degeneration (compare Fig. 4A with Fig. 1B ). In addition, peak total cGMP levels in light-adapted Pde6b H620Q retinas (at any time point) does not reach the same level as light-adapted Pde6b rd1 retinas at P14 (compare solid gray line to dashed line). Finally, to test whether partial loss of PDE6 function results in abnormal cGMP accumulation in Pde6b H620Q mutant retinas, we compared cGMP levels between mutant and control retinas (Fig.  4B) . However, at three time points, P14, P18, and P21, we found no significant differences in total cGMP in light-and dark-adapted retinas. These results complement our biochemical findings that Pde6b H620Q mutant retinas contain lightinduced PDE6 activity. Our data also suggest that this lower than normal level of PDE6 enzymatic activity is not sufficient to result in abnormal light-or dark-adapted total cGMP levels. However, these measurements of steady state total cGMP do not address the possibility that there may be differences in free cGMP between mutant and controls.
Abnormal Intracellular Ca 2؉ Levels in Pde6b
H620Q
Homozygous Mutant Outer Segments
In dark-adapted retinas, exposure to light results in activation of PDE6 and a rapid reduction of a small fraction of total cGMP (free cGMP) in the OS. These changes in free cGMP produce closure of cGMP-gated CNG channels and a reduction in the influx of Ca 2ϩ . Because Ca 2ϩ continues to be removed by the Na ϩ ,K ϩ ,Ca 2ϩ exchanger in the rod OS, Ca 2ϩ levels fall. As direct measurement of free cGMP is not tractable, we measured intracellular Ca 2ϩ directly in live Pde6b H620Q rod OS, using laser spot confocal microscopy. 53, 62 Eight mutant OS were evaluated: Dark-adapted Ca 2ϩ levels were 375 Ϯ 94 nM, whereas light-exposed levels were 92 Ϯ 18 nM. In contrast, in wild-type OS, dark-adapted and light-exposed Ca 2ϩ levels were 241 Ϯ 15 nM and 36 Ϯ 3 nM, respectively (Fig. 4C ). Student's t-test demonstrates that both darkadapted and light-exposed Ca 2ϩ levels are significantly different between mutant and wild-type rod OS (P ϭ 0.01035 and P Ͻ 0.00005, respectively). 53 The rates of Ca 2ϩ decreased in wild-type and mutant rods are similar. These data suggest that Ca 2ϩ levels (and, by extension, free cGMP) are significantly elevated in Pde6b H620Q rod OS, at least during a period after exposure to light of dark-adapted retinas.
Somatic Rescue of Photoreceptor Degeneration with an Opsin::Pde6b Lentivirus
Because Pde6b H620Q homozygous mice exhibit a hypomorphic degeneration phenotype, they may be amenable to gene therapy. We therefore introduced lentiviral vectors encoding wildtype Pde6b into Pde6b H620Q retinas and performed histologic and functional analyses.
Two vectors, Opsin::Pde6b and Opsin::Pde6b, EF1::GFP, were constructed (Fig. 5A) , and viral particles were prepared and injected subretinally into P5 Pde6b H620Q mice. Contralateral eyes received CMV::GFP lentivirus or saline injection as controls. To test transduction efficiency, Opsin::Pde6b, EF1::GFP-injected retinas were examined by live imaging. 63, 64 We found GFP fluorescence throughout the eye indicating widespread transduction (Fig. 5C ). Injection of Lenti-LacZ particles resulted in detectable ␤-galactosidase activity within Pde6b H620Q photoreceptors (Fig. 5D ). To determine the effect of Opsin::Pde6b transduction on the Pde6b H620Q degeneration phenotype, we performed a histologic study of 6-week-old transduced and control retinas (Figs. 5E, 5F ). Examination of H&E-stained serial sections showed a larger number of photoreceptor nuclei present in the Opsin::Pde6b-transduced retinas, compared to controls (Fig.  5E, top) . Peanut agglutinin staining showed that some of these rescued photoreceptors are cones (Fig. 5E, bottom) . Although control sections contain cones with shortened OS, in the rescued retinas cone OS are greater in length.
Quantitative analysis indicated an increased number of nuclei present along the optic nerve-to-periphery axis (Fig. 5F ). Although control mutants contained one to three photoreceptor nuclei, contralateral transduced retinas contained two to seven. These differences are not attributable to variation between animals, as the comparisons were performed on the same animals. In addition, the nuclei distribution in these control samples are representative of the range observed in 10 additional mutant eyes (Fig. 1B) . These results indicate that transduction of wild-type Pde6b into Pde6b H620Q mutant retinas can rescue the photoreceptor degeneration phenotype.
To test if Pde6b gene transfer improves retinal function, we performed serial ERGs on injected and control eyes between P14 and P90 (Figs. 5B, 6 ). In general, we observed significant differences in maximum b-wave amplitudes in rod and mixed rod-cone responses between injected and control eyes (Figs. 6A, 6B; Table 1 ). These differences became apparent after P55 and were sustained for several weeks. By P90, rod-specific injected ERGs were indistinguishable from control ERGs. In contrast, photopic cone responses were not significantly improved in injected eyes compared with the control (Fig. 6C) . Together, our histology and ERG data show that gene therapy can rescue the Pde6b H620Q degeneration phenotype.
DISCUSSION
We extended the initial phenotypic analysis of Pde6b
H620Q
homozygous mutant mice conducted by Hart et al. 42 
Homozygous Mutant Mice
Pde6b rd1 is a null allele, due to a nonsense mutation, and mutant mice exhibit abnormal photoreceptor differentiation and subsequent rapid rod degeneration. 35, 65 In particular, Pde6b rd1 OS are sparsely populated, disorganized, and truncated as early as P11, and rod degeneration is complete by 3 weeks. 9, 66 Before degeneration PDE6␤ expression, PDE6 activity, and retinal function are undetectable in these mice. 35, 43, 44 Associated with absence of PDE6 activity, Pde6b rd1 mice show no light-dependent changes in retinal total cGMP levels. [43] [44] [45] Moreover, since cGMP levels are abnormally high, relative to the control, it has been proposed that Ca 2ϩ influx through CNG channels promotes rod cell death in Pde6b rd1 mice. Although Pde6b H620Q mice also demonstrate progressive rod degeneration, our studies indicated phenotypic and biochemical features that are distinguishable from Pde6b rd1 mice. In particular, Pde6b H620Q mice initially exhibited relatively normal photoreceptor histology and physiology. Indeed, within 3 weeks after birth, Pde6b H620Q mutants expressed PDE6␤ and showed light-dependent PDE6 activity and detectable rod and cone function. However, residual Pde6b function detected in these mutants was not sufficient to maintain rod photoreceptor health indefinitely.
Partial Loss of PDE6 Function in Pde6b Homozygous Mutants
Consistent with the Pde6b H620Q being a hypomorphic allele, we observed PDE6␤ expression and PDE6 activity reduced in R560C . 67 Although both H620Q and R560C occur within the catalytic domain and may alter PDE6 activity, these mutations, and possibly others, may also affect PDE6␤ expression/stability. For our studies, age-matched DBA/2J or C57BL6 were used as the control, which were used previously for the analysis of the Pde6b rd1 allele. [42] [43] [44] [45] As these are not congenic with the C3H strain, which is the background for the Pde6b rd1 and Pde6b H620Q alleles, there may be some differences in the phenotypic parameters measured between these backgrounds.
Despite these expression and activity changes, we found light-adapted total cGMP level between Pde6b H620Q mutants and controls are not significantly different. We estimated the level of total PDE activity in the mutant retinas as ϳ0.6% of wild-type. This was due to the combined effect of reduced expression (1/22) and lower specific activity (1/7.7) in the mutants. How do we reconcile the fact that total light-adapted cGMP levels are the same between mutants and wild-type, while there is only 0.6% of PDE activity present in the retinas? One possibility is that this level of PDE activity, given enough time, is sufficient to reduce total cGMP to nominal levels under these conditions. Wild-type PDE activity is increased 300-fold by transducin activation and rapidly drives down total cGMP levels on the millisecond time-scale. 29 Since, in these experiments, we light adapted the mice at least 3 hours before isolation of total cGMP, mutant PDE may have had enough time to reduce total cGMP to nominal levels.
On a shorter-time scale, the effect of Pde6b loss of function may be more readily detectable. Indeed, our rod-specific ERGs suggest depressed and delayed photoreceptor hyperpolarization milliseconds after light stimulation. Similarly, we found abnormal reductions in intracellular Ca 2ϩ in mutant rod OS after light exposure. A common denominator between these assays is a changing concentration of free cGMP on a millisecond time-scale.
It has been proposed that high cGMP increases Ca 2ϩ influx through CNG channels to induce cell death. Regulation of intracellular Ca 2ϩ by cGMP is an important factor in maintaining photoreceptor health. 52, 68, 69 Our results showed for the first time in a Pde6b mutant model of RP, that Ca 2ϩ levels in living rod OS are significantly elevated. This finding was suspected to be the case in Pde6b rd1 mice, but was not testable because of malformation of rod OS in these mice. 70, 71 It is also a formal possibility that Ca 2ϩ independent factors are involved in initiating degeneration. 68, 72 
Retroviral Gene Therapy of Retinal Degeneration
Using lentiviral-mediated gene transfer, we can increase the number and significantly improve the function of Pde6b H620Q photoreceptors, which is a result not observed in previous attempts using Pde6b rd1 mice. 77 These findings also support our hypothesis that the previous attempts at viral gene therapy were, in part, limited by the severe null degeneration phenotype in Pde6b rd1 mice. As most human PDE6B mutations are missense alleles, features of Pde6b partial loss of function may more closely resemble human RP. The testing of pharmacologic and gene therapy strategies in Pde6b H620Q mice may yield tools for intervention in human photoreceptor specific diseases. Lessons learned in the Pde6b H620Q mouse may be translated into strategies for future treatments. 
